RPS Community of Practice lecture series: Dr Joseph Ioppolo

The National Imaging Facility – From the Point of View of a Radiochemistry Fellow in WA

Dr Joseph Ioppolo
National Imaging Facility (NIF) Radiochemistry Fellow for WA
Radiopharmaceutical Scientist at the RAPID, Cyclotron Laboratory at Sir Charles Gairdner Hospital.

Register your interest

Dear Colleagues

It gives me great pleasure to announce the fourth lecture for 2025, a presentation by Dr Joseph Ioppolo. Joe will talk about NIF and some of the activities that he has been involved in during the last few years. Over recent years, the National Imaging Facility (NIF) has partnered with universities and hospitals around the country to fund both radiochemistry positions and equipment. It has done this to provide infrastructure for researchers to more easily access radiopharmaceuticals for research use – both for imaging and therapy.

This talk aims to give a snapshot of what the NIF is about, and how this all works from the point of view of one of the Radiochemistry Fellows – with a particular perspective from WA. Some of the activities the WA NIF is involved with will be presented, with plenty of time for Q&A so bring your questions.

This is an exciting talk which illustrates the diversity of radiopharmaceuticals as more and more of our science is finding its way into the education and scientific communities, forming bridges with health.

The presentation will be available through TEAMS.

Yours Sincerely
Andrew Katsifis
Chair ACPSEM-Specialty Group

Biography

Dr Joseph Ioppolo.

Joseph (Joe) Ioppolo is the Radiochemistry Fellow for WA and has been in this role since 2022, working both for the WA NIF Node and RAPID, the cyclotron laboratory at Sir Charles Gairdner Hospital (which is just next door).

Prior to this he was a full-time chemist with the RAPID team, taking part in the production and quality control of clinical Carbon-11, Fluorine-18, Gallium-68, Zirconium-89 and Lutetium-177 radiopharmaceuticals…as well as plenty of routine FDG. Some projects he was involved with over that time included the introduction of [18F]PSMA-1007 into the clinical supply, as well some preclinical projects involving aluminium-fluoride labelling.

Although Joe is originally from Perth, he grew up and studied in Sydney and has spent parts of his ‘radiochemical life’ at SAHMRI, McMaster University, and at ANSTO.